Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with <i>MYD88</i> L265P mutation

Publication date

2024-02-19T17:13:37Z

2024-02-19T17:13:37Z

2023-07-04

2023-07-04T10:15:28Z

Document Type

Article


Published version

Language

English

Publisher

Ferrata Storti Foundation

Related items

Reproducció del document publicat a: https://doi.org/10.3324/haematol.2022.281988

Haematologica, 2022, 107, 12, 2990-2990

https://doi.org/10.3324/haematol.2022.281988

Recommended citation

This citation was generated automatically.

Rights

cc by-nc (c) Dlouhy, I. et al., 2022

http://creativecommons.org/licenses/by-nc/3.0/es/